Wilson-Costello D, Friedman H, Minich N, et al. Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s. Pediatrics. 2005;115:997–1003.

Article  PubMed  Google Scholar 

Manuck TA, Sheng X, Yoder BA, et al. Correlation between initial neonatal and early childhood outcomes following preterm birth. Am J Obstet Gynecol. 2014;210(426):e1-426.e9.

Google Scholar 

Himpens E, Van den Broeck C, Oostra A, Calders P, Vanhaesebrouck P. Prevalence, type, distribution, and severity of cerebral palsy in relation to gestational age: a meta-analytic review. Dev Med Child Neurol. 2008;50:334–40.

Article  CAS  PubMed  Google Scholar 

Usman S, Foo L, Tay J, Bennett PR, Lees C. Use of magnesium sulfate in preterm deliveries for neuroprotection of the neonate. Obstet Gynaecol. 2017;19:21–8.

Article  Google Scholar 

Chollat C, Sentilhes L, Marret S. Fetal neuroprotection by magnesium sulfate: from translational research to clinical application. Front Neurol. 2018;9:247. https://doi.org/10.3389/fneur.2018.00247.

Article  PubMed  PubMed Central  Google Scholar 

Kuban KCK, Leviton A, Pagano M, et al. Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies. J Child Neurol. 1992;7:70–6.

Article  CAS  PubMed  Google Scholar 

Weintraub Z, Solovechick M, Reichman B, et al. Effect of maternal tocolysis on the incidence of severe periventricular/intraventricular haemorrhage in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 2001;85:F13–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reeves S, Gibbs R, Clark S. Magnesium for fetal neuroprotection. Am J Obstet Gynecol. 2011;204:e1–4.

Article  Google Scholar 

Doyle LW, Crowther CA, Middleton P, et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2009;1:CD004661.

Google Scholar 

Zeng X, Xue Y, Tian Q, Sun R, An R. Effects and safety of magnesium sulfate on neuroprotection. Medicine (Baltimore). 2016;95(1):2451.

Article  Google Scholar 

WHO recommendations on interventions to improve preterm birth outcomes: evidence base.2015.https://apps.who.int/iris/bitstream/handle/10665/183037/9789241508988_eng.pdf

James MF. Magnesium in obstetrics. Best Pract Res Clin Obstet Gynaecol. 2010;24:327–37.

Article  CAS  PubMed  Google Scholar 

Conde-Agudelo A, Romero R. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks’ gestation: a systematic review and metaanalysis. Am J Obstet Gynecol. 2009;200:595–609.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eng.-3-yrs-Milestone-Moments-Checklist-2021-P.pdf. American academy of Paediatrics . www.cdc.gov.

Bayley N. Bayley scales of infant development. 2nd ed. New York: Psychological Corporation; 1993.

Google Scholar 

Shennan A, Suff N, Jacobsson B. FIGO good practice recommendations on magnesium sulfate administration for preterm fetal neuroprotection. Int J Gynecol Obstet. 2021;155:31–3.

Article  CAS  Google Scholar 

Magee LA, De Silva DA, Sawchuck D, Synnes A, von Dadelszen P. Magnesium sulphate for fetal neuroprotection. J Obstet Gynaecol Can. 2019;41(4):505–22. https://doi.org/10.1016/j.jogc.2018.09.018.

Article  PubMed  Google Scholar 

Rouse DJ, Hirtz DG, Thom E, et al. A randomized controlled trial of magnesium sulfate for the prevention of cerebral palsy. BEAM trial N Engl J Med. 2008;359:895–905.

Article  CAS  Google Scholar 

Bachnas MA, Akbar MIA, Dachlan EG, Dekker G. The role of magnesium sulfate (MgSO4) in fetal neuroprotection. J Matern Fetal Neonatal Med. 2021;34(6):966–78.

Article  CAS  PubMed  Google Scholar 

Van Laecke S. Hypomagnesemia and hypermagnesemia. Acta Clin Belg. 2019;74(1):41–7.

Article  PubMed  Google Scholar 

Ginsberg Y, Gutzeit O, Khatib N, Weiner Z, Bang S, Beloosesky R, et al. Magnesium sulphate doses for neuroprotection : low is better. Am J Obstet Gynecol. 2021;224(2):s294.

Article  Google Scholar 

Moradi Y, Khateri R, Haghighi L, Dehghani S, Hanis SM, Valipour M, et al. The effect of antenatal magnesium sulfate on intraventricular hemorrhage in premature infants: a systematic review and meta-analysis. Obstet Gynecol Sci. 2020;63:395–406.

Article  PubMed  PubMed Central  Google Scholar 

Gibbins KJ, Browning KR, Lopes VV, et al. Evaluation of the clinical use of magnesium sulfate for cerebral palsy prevention. Obstet Gynecol. 2013;121:235–40.

Article  CAS  PubMed  Google Scholar 

Kimberlin DF, Hauth JC, Goldenberg RL, Bottoms SF, Iams JD, Mercer B, et al. The effect of maternal magnesium sulfate treatment on neonatal morbidity in < or = 1000- gram infants. Am J Perinatol. 1998;15(11):635–41.

Article  CAS  PubMed  Google Scholar 

Shepherd E, Salam RA, Manhas D, Synnes A, Middleton P, Makrides M, et al. Antenatal magnesium sulphate and adverse neonatal outcomes: a systematic review and meta-analysis. PLoS Med. 2019;16: e1002988.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mittendorf R, Dambrosia J, Pryde PG, et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol. 2002;186:1111–8.

Article  CAS  PubMed  Google Scholar 

Bansal V, Desai A. Efficacy of antenatal magnesium sulfate for neuroprotection in extreme prematurity: a comparative observational study. J Obstet Gynaecol India. 2021;72(S1):36–47.

Article  PubMed  PubMed Central  Google Scholar